Karlheinz Peter Atherothrombosis and Vascular Biology Baker Heart & Diabetes Institute Biography Publications Institution JoVE Articles Karlheinz Peter has not added a biography. If you are Karlheinz Peter and would like to personalize this page please email our Author Liaison for assistance. Publications Dual-Targeted Theranostic Delivery of MiRs Arrests Abdominal Aortic Aneurysm Development Molecular Therapy : the Journal of the American Society of Gene Therapy. 04, 2018 | Pubmed ID: 29525742 A Ligand-specific Blockade of the Integrin Mac-1 Selectively Targets Pathologic Inflammation While Maintaining Protective Host-defense Nature Communications. 02, 2018 | Pubmed ID: 29410422 Mesoscale Nanoparticles: An Unexpected Means for Selective Therapeutic Targeting of Kidney Diseases! Hypertension (Dallas, Tex. : 1979). 01, 2018 | Pubmed ID: 29133359 Génération de Nanoliposomes cationiques pour la prestation efficace de In Vitro transcrit l’ARN messager Tatjana Michel1, Antonia Link1, Meike-Kristin Abraham1,2, Christian Schlensak1, Karlheinz Peter2,3, Hans-Peter Wendel1, Xiaowei Wang2,3, Stefanie Krajewski1 1Department of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center, 2Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute, 3Department of Medicine, Monash University JoVE 58444 Bioengineering
Génération de Nanoliposomes cationiques pour la prestation efficace de In Vitro transcrit l’ARN messager Tatjana Michel1, Antonia Link1, Meike-Kristin Abraham1,2, Christian Schlensak1, Karlheinz Peter2,3, Hans-Peter Wendel1, Xiaowei Wang2,3, Stefanie Krajewski1 1Department of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center, 2Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute, 3Department of Medicine, Monash University JoVE 58444 Bioengineering
